Literature DB >> 15319001

Hemin induces heme oxygenase-1 in spinal cord vasculature and attenuates barrier disruption and neutrophil infiltration in the injured murine spinal cord.

Toshihiro Yamauchi1, Yong Lin, Frank R Sharp, Linda J Noble-Haeusslein.   

Abstract

Heme oxygenase-1 (HO-1) has been shown to alter vascular function in part by attenuating inflammation. We induced HO-1 in blood vessels in the spinal cord by systemic administration of hemin. Twenty-four hours later, immediately prior to euthanasia, fluorescence conjugated Lycopersicon esculentum (tomato) lectin was given intravenously to label the vasculature. HO-1 was induced in blood vessels, particularly in the white matter, as evidenced by the immunolocalization of HO-1 in lectin positive vessels. Western blots confirmed the hemin-mediated induction of HO-1 in the uninjured spinal cord. We next examined the extent to which treatment with hemin or vehicle, 24 h prior to a moderate contusion injury, influenced early vascular dysfunction in the injured cord. All animals were euthanized 24 h after injury. Luciferase, a marker of barrier integrity, was given intravenously 30 min prior to euthanasia. The spinal cord was either prepared for quantification of luciferase activity or fixed by vascular perfusion and prepared for the immunolocalization of neutrophils. There was a significant attenuation of barrier permeability to luciferase and a significant reduction in the number of neutrophils in hemin treated animals as compared to the vehicle treated group. Together, these findings demonstrate that vascular induction of HO-1 modulates barrier function and neutrophil infiltration and suggest that this protein may be useful for limiting the early vascular dysfunction and inflammation that occurs in the acutely injured spinal cord. Copyright 2004 Mary Ann Liebert, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15319001     DOI: 10.1089/0897715041651042

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  22 in total

1.  Vascular Pathology as a Potential Therapeutic Target in SCI.

Authors:  Richard L Benton; Theo Hagg
Journal:  Transl Stroke Res       Date:  2011-11-29       Impact factor: 6.829

2.  Targeting heme oxygenase after intracerebral hemorrhage.

Authors:  Jing Chen-Roetling; Xiangping Lu; Raymond F Regan
Journal:  Ther Targets Neurol Dis       Date:  2015-01-03

3.  Systemic hemin therapy attenuates blood-brain barrier disruption after intracerebral hemorrhage.

Authors:  Xiangping Lu; Jing Chen-Roetling; Raymond F Regan
Journal:  Neurobiol Dis       Date:  2014-06-18       Impact factor: 5.996

Review 4.  Targeting microvasculature for neuroprotection after SCI.

Authors:  Janelle M Fassbender; Scott R Whittemore; Theo Hagg
Journal:  Neurotherapeutics       Date:  2011-04       Impact factor: 7.620

5.  Matrix Metalloproteinase-8 Inhibition Prevents Disruption of Blood-Spinal Cord Barrier and Attenuates Inflammation in Rat Model of Spinal Cord Injury.

Authors:  Hemant Kumar; Min-Jae Jo; Hyemin Choi; Manjunatha S Muttigi; Seil Shon; Byung-Joo Kim; Soo-Hong Lee; In-Bo Han
Journal:  Mol Neurobiol       Date:  2017-04-18       Impact factor: 5.590

6.  Melatonin prevents blood vessel loss and neurological impairment induced by spinal cord injury in rats.

Authors:  Yingli Jing; Fan Bai; Hui Chen; Hao Dong
Journal:  J Spinal Cord Med       Date:  2016-10-13       Impact factor: 1.985

Review 7.  Targeting the Nrf2-Heme Oxygenase-1 Axis after Intracerebral Hemorrhage.

Authors:  Jing Chen-Roetling; Raymond F Regan
Journal:  Curr Pharm Des       Date:  2017       Impact factor: 3.116

8.  Prevention of clinical and histological signs of proteolipid protein (PLP)-induced experimental allergic encephalomyelitis (EAE) in mice by the water-soluble carbon monoxide-releasing molecule (CORM)-A1.

Authors:  P Fagone; K Mangano; C Quattrocchi; R Motterlini; R Di Marco; G Magro; N Penacho; C C Romao; F Nicoletti
Journal:  Clin Exp Immunol       Date:  2011-01-14       Impact factor: 4.330

Review 9.  Propitious Therapeutic Modulators to Prevent Blood-Spinal Cord Barrier Disruption in Spinal Cord Injury.

Authors:  Hemant Kumar; Alexander E Ropper; Soo-Hong Lee; Inbo Han
Journal:  Mol Neurobiol       Date:  2016-05-18       Impact factor: 5.590

10.  Hepatic Overexpression of Hemopexin Inhibits Inflammation and Vascular Stasis in Murine Models of Sickle Cell Disease.

Authors:  Gregory M Vercellotti; Ping Zhang; Julia Nguyen; Fuad Abdulla; Chunsheng Chen; Phong Nguyen; Carlos Nowotny; Clifford J Steer; Ann Smith; John D Belcher
Journal:  Mol Med       Date:  2016-07-19       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.